Compromised natural killer cells in pulmonary embolism

Area of Science:

• Immunology
• Pulmonary Medicine
• Genomics

Background:

• Pulmonary embolism (PE) is a significant global health issue with high rates of morbidity, mortality, and misdiagnosis.
• The exact causes and disease mechanisms of PE remain incompletely understood.
• Emerging evidence highlights the critical involvement of infection and immune responses in PE pathogenesis.

Purpose of the Study:

• To investigate the potential role and function of natural killer (NK) cells in the context of pulmonary embolism.
• To explore the relationship between NK cell activity and the development of PE.

Main Methods:

• Human cDNA microarray analysis was used to identify genes related to NK cells in peripheral blood mononuclear cells (PBMCs).
• Differential gene expression was statistically analyzed using a random variance model corrected t-test.
• Flow cytometry was employed to quantify the proportion of CD16+CD56+ NK cells.

Main Results:

• Microarray analysis revealed significant downregulation of key NK cell receptors, including inhibitory receptors (KLRB1, KLRD1, KLRF1, KLRG1) and activating receptors (KLRC1, KLRC3, KLRK1, NCR1).
• Cytological experiments confirmed a decreased proportion of CD16+CD56+ NK cells within PBMCs in patients with PE.
• Genomic and cytological findings were consistent, indicating a potential impairment in NK cell function.

Conclusions:

• Reduced expression of critical NK cell activating and inhibitory receptors was confirmed in PE patients.
• A lower proportion of CD16+CD56+ NK cells was observed in individuals with PE.
• The concordance between genomic and cytological data supports the hypothesis that compromised NK cell function may contribute to the pathogenesis of PE.